Overview Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary This study is to compare the efficacy and safety of increasing doses of SLV306 with amlodipine. Phase: Phase 2 Details Lead Sponsor: Solvay Pharmaceuticals